News Links
Research News From December 21, 2016
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery. MD-Logic Overnight Type 1 Diabetes Control in Home Settings: Multicenter, Multinational, Single blind, Randomized Trial. Incidence of type 1 diabetes has doubled in Kuwaiti children 0-14 years over the last 20 years. Similar pharmacokinetics and pharmacodynamics of rapid-acting insulin lispro products SAR342434 and US- and EU-approved Humalog® in subjects with type 1 diabetes. Evaluation of the Counter-regulatory Responses to Hypoglycemia in Patients with Type 1 Diabetes during Opiate Receptor Blockade with Naltrexone.
Read MorePress Releases for December 14, 2016
Lilly Announces Program to Provide Insulin at Discounted Prices.
Read MorePopular Press for December 14, 2016
Ed Damiano: WebMD’s 2016 Health Hero. The Interesting Way Alan Thicke Helped With Juvenile Diabetes, Because His Legacy Lives On. Scottish diabetes equipment funding increase. Lower-Cost Canadian Health Care as Good as U.S.’s for Low-Income Kids with Diabetes. Challenges, misconceptions abound for kids with T1 diabetes. Why diabetes patients can’t buy generic insulin. ‘It Was a Weird and Dark Place’: How Women with Diabulimia Dice with Death.
Read MoreLegislative and Policy News for December 14, 2016
Among Low-Income Respondents With Diabetes, High-Deductible Versus No-Deductible Insurance Sharply Reduces Medical Service Use. Some people spend as much on insulin as their mortgage — and drugmakers are taking note.
Read MoreCeliac News for December 14, 2016
New insights into wheat toxicity: Breeding did not seem to contribute to a prevalence of potential celiac disease’s immunostimulatory epitopes. See also New wheat crops as an alternative to a gluten-free diet. Celiac patients detected during type 1 diabetes surveillance had similar issues to those diagnosed on a clinical basis. Anxiety and depression in caregivers of individuals with celiac disease – A population-based study. Has wheat gluten changed over time? Quality project seeks to find out.
Read MoreDaily Care News for December 14, 2016
Lower Basal Insulin Dose is Associated with Better Control in Type 1 Diabetes. Changes in cardiac repolarisation during spontaneous nocturnal hypoglycemia in subjects with type 1 diabetes: a preliminary report. Glucose Exposure and Variability with Empagliflozin as Adjunct to Insulin in Patients with Type 1 Diabetes: Continuous Glucose Monitoring Data from a 4-Week, Randomized, Placebo-Controlled Trial (EASE-1). Metabolic ketoacidosis with normal blood glucose: A rare complication of sodium-glucose cotransporter 2 inhibitors. Free full text available in HTML and PDF formats. The economic impact of insulin-related hypoglycemia in Denmark: an analysis using the Local Impact of Hypoglycemia Tool. Diabetes Distress Among Persons With Type 1 […]
Read MoreResearch News From December 14, 2016
β-cell–mimetic designer cells provide closed-loop glycemic control. Coxsackie-adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes. Free full text available in HTML and PDF formats. Metformin in adults with type 1 diabetes: design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): an international multicentre trial.
Read MorePress Releases for December 7, 2016
ONE DROP Announces FDA Clearance and ONE DROP | Premium Launch in US, UK, and EU. Genteel: “For Those with Diabetes, Painful Blood Sugar Checks Are Now a Thing of the Past”.
Read MorePopular Press for December 7, 2016
When it’s not just the flu: Kids with Type 1 diabetes often misdiagnosed due to the rapid onset of common symptoms. Richard Goyder and Ian Narev’s pursuit of a type 1 diabetes cure. Type 1 Inspiration: A Diabetes Diagnosis Didn’t Stop This Girl. Type A Personality, Type 1 Diabetes — A Student’s Perspective. What’s Your Type: Diabetes Awareness. Global aid program expands to provide poor children with free type 1 diabetes care. One in five Australians with type 1 diabetes is hypo-unaware, study finds. Public, professional education needed about type 1 diabetes symptoms.
Read More